• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管外心脏再同步治疗除颤器的一个适应证:心外膜心脏再同步治疗与皮下植入式心脏复律除颤器联合治疗病例的经验教训。

One Indication for an Extravascular Cardiac Resynchronization Therapy Defibrillator: Lessons from a Combination Therapy Case with Epicardial Cardiac Resynchronization Therapy and a Subcutaneous Implantable Cardioverter Defibrillator.

机构信息

Department of Cardiovascular internal medicine, National Cerebral and Cardiovascular Center, Japan.

Graduate School of Medical Sciences Kumamoto University, Japan.

出版信息

Intern Med. 2021 Jun 15;60(12):1877-1880. doi: 10.2169/internalmedicine.6125-20. Epub 2021 Feb 1.

DOI:10.2169/internalmedicine.6125-20
PMID:33518564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8263187/
Abstract

Extravascular cardiac resynchronization therapy (CRT) defibrillators (CRT-Ds) are ideal for recurrent blood stream infections. Furthermore, CRT is useful for patients intolerant to right ventricular (RV) pacing. The case was a 65-year-old man with a CRT-D who presented with a blood stream infection. Because he was hemodynamically unstable with temporary RV pacing, an epicardial CRT device was re-implanted concomitantly through a surgical procedure. After the operation, a subcutaneous implantable cardioverter defibrillator (S-ICD) was placed. However, not all pacing is eligible for S-ICD screening. Combination therapy with an epicardial CRT device and S-ICD might be an alternate option for cardiac surgery cases.

摘要

血管外心脏再同步治疗除颤器(CRT-D)是复发性血流感染的理想选择。此外,对于不能耐受右心室(RV)起搏的患者,CRT 也很有用。该病例为一名 65 岁男性,植入 CRT-D 后发生血流感染。由于他在 RV 临时起搏时血流动力学不稳定,因此通过手术同时重新植入心外膜 CRT 装置。手术后,放置了皮下植入式心律转复除颤器(S-ICD)。然而,并非所有起搏都符合 S-ICD 筛查标准。心外膜 CRT 装置和 S-ICD 的联合治疗可能是心脏手术病例的另一种选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49e6/8263187/0b18f6ab687e/1349-7235-60-1877-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49e6/8263187/e9014a99ae23/1349-7235-60-1877-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49e6/8263187/0b18f6ab687e/1349-7235-60-1877-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49e6/8263187/e9014a99ae23/1349-7235-60-1877-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49e6/8263187/0b18f6ab687e/1349-7235-60-1877-g002.jpg

相似文献

1
One Indication for an Extravascular Cardiac Resynchronization Therapy Defibrillator: Lessons from a Combination Therapy Case with Epicardial Cardiac Resynchronization Therapy and a Subcutaneous Implantable Cardioverter Defibrillator.血管外心脏再同步治疗除颤器的一个适应证:心外膜心脏再同步治疗与皮下植入式心脏复律除颤器联合治疗病例的经验教训。
Intern Med. 2021 Jun 15;60(12):1877-1880. doi: 10.2169/internalmedicine.6125-20. Epub 2021 Feb 1.
2
The mortality analysis of primary prevention patients receiving a cardiac resynchronization defibrillator (CRT-D) or implantable cardioverter-defibrillator (ICD) according to guideline indications in the improve SCA study.根据改善 SCA 研究中的指南指征,对接受心脏再同步除颤器 (CRT-D) 或植入式心律转复除颤器 (ICD) 的一级预防患者进行死亡率分析。
J Cardiovasc Electrophysiol. 2021 Aug;32(8):2285-2294. doi: 10.1111/jce.15149. Epub 2021 Jul 9.
3
Response of right ventricular size to treatment with cardiac resynchronization therapy and the risk of ventricular tachyarrhythmias in MADIT-CRT.心脏再同步治疗对右心室大小的反应与 MADIT-CRT 中室性心律失常的风险。
Heart Rhythm. 2013 Oct;10(10):1471-7. doi: 10.1016/j.hrthm.2013.07.029. Epub 2013 Jul 19.
4
The association between biventricular pacing and cardiac resynchronization therapy-defibrillator efficacy when compared with implantable cardioverter defibrillator on outcomes and reverse remodelling.双心室起搏与心脏再同步治疗除颤器在疗效、预后和逆重构方面与植入式心脏复律除颤器的比较。
Eur Heart J. 2015 Feb 14;36(7):440-8. doi: 10.1093/eurheartj/ehu294. Epub 2014 Aug 11.
5
Use of Cardiac Resynchronization Therapy Among Eligible Patients Receiving an Implantable Cardioverter Defibrillator: Insights From the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry.在接受植入式心脏复律除颤器的合格患者中使用心脏再同步治疗:来自国家心血管数据注册植入式心脏复律除颤器登记处的见解。
JAMA Cardiol. 2017 May 1;2(5):561-565. doi: 10.1001/jamacardio.2016.5388.
6
Upgrade from implantable cardioverter-defibrillator vs. de novo implantation of cardiac resynchronization therapy: long-term outcomes.从植入式心脏复律除颤器升级与重新植入心脏再同步治疗:长期结果。
Europace. 2021 Jan 27;23(1):113-122. doi: 10.1093/europace/euaa339.
7
The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).心脏再同步治疗除颤器与植入式心脏复律除颤器患者中,间歇性房性快速心律失常对心力衰竭或死亡的影响:MADIT-CRT 亚研究(多中心自动除颤器植入试验与心脏再同步治疗)。
J Am Coll Cardiol. 2014 Apr 1;63(12):1190-1197. doi: 10.1016/j.jacc.2013.10.074. Epub 2013 Dec 11.
8
Association of body mass index with cardiac resynchronization therapy intention and left ventricular lead implantation failure: insights from the NCDR implantable cardioverter-defibrillator registry.体重指数与心脏再同步治疗意图和左心室导线植入失败的相关性:来自 NCDR 植入式心脏复律除颤器登记处的见解。
J Interv Card Electrophysiol. 2020 Mar;57(2):279-288. doi: 10.1007/s10840-019-00550-x. Epub 2019 Apr 19.
9
Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.心力衰竭合并心房颤动患者心脏再同步治疗的比较效果:来自国家心血管数据注册中心植入式心律转复除颤器注册研究的结果
Circ Heart Fail. 2016 Jun;9(6). doi: 10.1161/CIRCHEARTFAILURE.115.002324.
10
Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.左束支传导阻滞的轻度心力衰竭患者接受心脏再同步治疗的长期预后的性别差异
J Am Heart Assoc. 2015 Jun 29;4(7):e002013. doi: 10.1161/JAHA.115.002013.

引用本文的文献

1
S-ICD Implantation "Tips and Tricks".皮下植入式心律转复除颤器(S-ICD)植入术“技巧与窍门”
Rev Cardiovasc Med. 2023 Jul 10;24(7):195. doi: 10.31083/j.rcm2407195. eCollection 2023 Jul.

本文引用的文献

1
Implantation of left atrial-ventricular epicardial pacemaker system and subcutaneous implantable cardioverter-defibrillator in a single setting: The "extravascular" cardiac resynchronization therapy.同期植入左房室心外膜起搏器系统和皮下植入式心律转复除颤器:“血管外”心脏再同步治疗
HeartRhythm Case Rep. 2019 Mar 6;5(7):354-358. doi: 10.1016/j.hrcr.2019.02.010. eCollection 2019 Jul.
2
Managing cross talk between a subcutaneous implantable cardioverter-defibrillator and a dual-chamber unipolar pacemaker system.管理皮下植入式心律转复除颤器与双腔单极起搏器系统之间的串扰。
HeartRhythm Case Rep. 2017 Sep 1;3(12):579-583. doi: 10.1016/j.hrcr.2017.08.004. eCollection 2017 Dec.
3
Surgical and electrophysiological considerations in the management of a patient with a subcutaneous implantable cardioverter-defibrillator undergoing coronary artery bypass surgery.
接受冠状动脉搭桥手术的皮下植入式心脏复律除颤器患者管理中的外科和电生理考量
HeartRhythm Case Rep. 2016 Oct 24;3(1):58-62. doi: 10.1016/j.hrcr.2016.09.002. eCollection 2017 Jan.
4
Nothing inside the heart - Combining epicardial pacing with the S-ICD.心脏内部无异物——将心外膜起搏与皮下植入式心律转复除颤器相结合。
HeartRhythm Case Rep. 2015 Sep 4;1(6):419-423. doi: 10.1016/j.hrcr.2015.04.001. eCollection 2015 Nov.